Agnesian HealthCare News

Injectable steroids under question not available through Agnesian HealthCare

October 09, 2012

Agnesian HealthCare does not utilize an injectable steroid product (methylprednisolone acetate) that is under question by the Centers for Disease Control (CDC) in 23 states as people are developing a rare form of fungal meningitis.

Methylprednisolone acetate is an injectable steroid product used to treat pain and inflammation when oral therapy is not feasible. It is injected into the spine.

“We are working to reassure those patients that have received pain treatments through Agnesian HealthCare that we do not utilize products from the New England Compounding Center,” according to Joy Schultz, PharmD, inpatient pharmacy director with Agnesian HealthCare. “The facilities who received the lots recalled are actively contacting patients to find out if they are feeling well.”